Show simple item record

dc.contributor.authorCheungpasitporn, Wisit
dc.contributor.authorThongprayoon, Charat
dc.contributor.authorVaitla, Pradeep K
dc.contributor.authorChewcharat, Api
dc.contributor.authorHansrivijit, Panupong
dc.contributor.authorKoller, Felicitas L
dc.contributor.authorMao, Michael A
dc.contributor.authorBathini, Tarun
dc.contributor.authorSalim, Sohail Abdul
dc.contributor.authorKatari, Sreelatha
dc.contributor.authorCummings, Lee S
dc.contributor.authorIsland, Eddie
dc.contributor.authorForster, Jameson
dc.contributor.authorLeeaphorn, Napat
dc.date.accessioned2020-07-15T23:47:01Z
dc.date.available2020-07-15T23:47:01Z
dc.date.issued2020-05-14
dc.identifier.citationCheungpasitporn, W.; Thongprayoon, C.; Vaitla, P.K.; Chewcharat, A.; Hansrivijit, P.; Koller, F.L.; Mao, M.A.; Bathini, T.; Salim, S.A.; Katari, S.; Cummings, L.S.; Island, E.; Forster, J.; Leeaphorn, N. Degree of Glomerulosclerosis in Procurement Kidney Biopsies from Marginal Donor Kidneys and Their Implications in Predicting Graft Outcomes. J. Clin. Med. 2020, 9, 1469.en_US
dc.identifier.issn2077-0383
dc.identifier.pmid32422905
dc.identifier.doi10.3390/jcm9051469
dc.identifier.urihttp://hdl.handle.net/10150/641873
dc.description.abstractBackground: This study aimed to assess the association between the percentage of glomerulosclerosis (GS) in procurement allograft biopsies from high-risk deceased donor and graft outcomes in kidney transplant recipients. Methods: The UNOS database was used to identify deceased-donor kidneys with a kidney donor profile index (KDPI) score > 85% from 2005 to 2014. Deceased donor kidneys were categorized based on the percentage of GS: 0-10%, 11-20%, >20% and no biopsy performed. The outcome included death-censored graft survival, patient survival, rate of delayed graft function, and 1-year acute rejection. Results: Of 22,006 kidneys, 91.2% were biopsied showing 0-10% GS (58.0%), 11-20% GS (13.5%), >20% GS (19.7%); 8.8% were not biopsied. The rate of kidney discard was 48.5%; 33.6% in 0-10% GS, 68.9% in 11-20% GS, and 77.4% in >20% GS. 49.8% of kidneys were discarded in those that were not biopsied. Death-censored graft survival at 5 years was 75.8% for 0-10% GS, 70.9% for >10% GS, and 74.8% for the no biopsy group. Among kidneys with >10% GS, there was no significant difference in death-censored graft survival between 11-20% GS and >20% GS. Recipients with >10% GS had an increased risk of graft failure (HR = 1.27, p < 0.001), compared with 0-10% GS. There was no significant difference in patient survival, acute rejection at 1-year, and delayed graft function between 0% and 10% GS and >10% GS. Conclusion: In >85% KDPI kidneys, our study suggested that discard rates increased with higher percentages of GS, and GS >10% is an independent prognostic factor for graft failure. Due to organ shortage, future studies are needed to identify strategies to use these marginal kidneys safely and improve outcomes.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rightsCopyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectglomerulosclerosisen_US
dc.subjectkidney transplantationen_US
dc.subjectoutcomesen_US
dc.subjectprocurement kidney biopsyen_US
dc.subjectTransplantationen_US
dc.titleDegree of Glomerulosclerosis in Procurement Kidney Biopsies from Marginal Donor Kidneys and Their Implications in Predicting Graft Outcomesen_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizona, Dept Internal Meden_US
dc.identifier.journalJOURNAL OF CLINICAL MEDICINEen_US
dc.description.noteOpen access journalen_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal published versionen_US
dc.source.journaltitleJournal of clinical medicine
dc.source.volume9
dc.source.issue5
refterms.dateFOA2020-07-15T23:47:02Z
dc.source.countrySwitzerland


Files in this item

Thumbnail
Name:
jcm-09-01469.pdf
Size:
1.661Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).